US Patent Issued to NURIX THERAPEUTICS on March 24 for "Bifunctional compounds for degrading BTK via ubiquitin proteosome pathway" (California Inventors)

ALEXANDRIA, Va., March 24 -- United States Patent no. 12,583,862, issued on March 24, was assigned to NURIX THERAPEUTICS INC. (San Francisco).

"Bifunctional compounds for degrading BTK via ubiquitin proteosome pathway" was invented by Daniel W. Robbins (San Francisco), Arthur T. Sands (San Francisco), Joel Mcintosh (San Francisco), Jeffrey Mihalic (San Francisco), Jeffrey Wu (San Francisco), Daisuke Kato (San Francisco), Dahlia Weiss (San Francisco) and Ge Peng (San Francisco).

According to the abstract* released by the U.S. Patent & Trademark Office: "The present invention relates to compounds useful for degrading BTK via a ubiquitin proteolytic pathway. The invention also provides pharmaceutically acceptable compositions comprising said...